Literature DB >> 11762932

Inflammatory bowel disease and spondylarthropathy.

S Smale1, R S Natt, T R Orchard, A S Russell, I Bjarnason.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11762932     DOI： 10.1002/1529-0131(200112)44:12<2728::aid-art459>3.0.co;2-8

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  31 in total

Review 1.  Extraintestinal complications of inflammatory bowel disease.

Authors:  Tim Orchard
Journal:  Curr Gastroenterol Rep       Date:  2003-12

2.  COX 2 inhibition and bowel strictures.

Authors:  L P Maiden; I Bjarnason
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 3.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  IBD: IBD and spondyloarthritis: joint management.

Authors:  Paolo Gionchetti; Fernando Rizzello
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-16       Impact factor: 46.802

Review 5.  Management of arthropathy in inflammatory bowel diseases.

Authors:  Rosario Peluso; Francesco Manguso; Maria Vitiello; Salvatore Iervolino; Matteo Nicola Dario Di Minno
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

Review 6.  Blau syndrome and related genetic disorders causing childhood arthritis.

Authors:  Mara L Becker; Carlos D Rose
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 7.  The treatment of the rheumatological manifestations of the inflammatory bowel diseases.

Authors:  Melissa Padovan; Gabriella Castellino; Marcello Govoni; Francesco Trotta
Journal:  Rheumatol Int       Date:  2006-06-24       Impact factor: 2.631

8.  [NSAID-colonopathy].

Authors:  M Vieth
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

Review 9.  Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Jurij Hanzel; Christopher Ma; Niels Vande Casteele; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

10.  NSAIDs: the emperor's new dogma?

Authors:  I Bjarnason; K Takeuchi; R Simpson
Journal:  Gut       Date:  2003-09       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.